Extra correct ageing clock depends solely on medical knowledge

Extra correct ageing clock depends solely on medical knowledge

A new algorithm-based biological ageing clock developed in Singapore has shown potential to better predict mortality and health outcomes by only using clinical data.  Researchers from the National University of Singapore’s Yong Loo Lin School of Medicine (NUS Medicine) recently introduced an updated version of their existing biological ageing models to more accurately assess a … Read more

Atropos Well being, Databricks companion for information sharing

Atropos Well being, Databricks companion for information sharing

Atropos Health, a company that translates real-world clinical data into real-world evidence, announced a  partnership with Databricks, a data intelligence and AI provider. By expanding on the Databricks Data Intelligence Platform and leveraging delta sharing, Atropos Health aims to enable clinicians and researchers to create actionable insights to increase drug discoveries and reduce the time … Read more

Unique: Pangaea Information, AstraZeneca’s Alexion accomplice to identify uncommon illness with EHRs

Unique: Pangaea Information, AstraZeneca’s Alexion accomplice to identify uncommon illness with EHRs

Pangaea Data, a company focused on detecting hard-to-diagnose diseases in patients, is partnering with Alexion, a subsidiary of AstraZeneca focused on treating rare diseases, to co-develop, clinically validate and ultimately seek regulatory approval for an AI-enabled offering to detect hypophosphatasia in adults. “Alexion entered into a multi-collaboration agreement with Pangaea a few months ago, which has … Read more

Unique: Pangea Information, AstraZeneca’s Alexion companion to identify uncommon illness with EHRs

Unique: Pangea Information, AstraZeneca’s Alexion companion to identify uncommon illness with EHRs

Pangea Data, a company focused on detecting rare diseases in patients, is partnering with Alexion, a subsidiary of AstraZeneca focused on treating rare diseases, to co-develop, clinically validate and ultimately seek regulatory approval for an AI-enabled offering to detect hypophosphatasia in adults. “Alexion entered into a multi-collaboration agreement with Pangea a few months ago, which … Read more